Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Understanding brain function requires going beyond what the BOLD signal alone can tell us. Functional MRI has transformed human neuroscience, but its haemodynamic basis means it captures neural activity only indirectly and cannot disambiguate the neurochemical processes that drive it. Functional MRS (fMRS) measures dynamic changes in neurometabolite concentrations — most notably glutamate, GABA, and lactate — in vivo, offering a more direct readout of the excitation-inhibition balance underlying brain responses. In this talk, I will present a series of 7T studies that explore the complementary natureof fMRS and fMRI, and ask what fMRS adds that fMRI cannot provide on its own.

Across paradigms ranging from sensory and motor tasks to pharmacological challenges, we show that neurometabolic and haemodynamic responses are related but dissociable, carrying partially non-overlapping information about neural processes. Extending fMRS to simultaneous multi-voxel acquisitions further reveals distributed neurochemical dynamics that spatially constrained designs would miss, while integrating fMRS with fMRI connectivity analyses allows drug-induced neurometabolic changes to be linked to network-level reorganisation across neurotransmitter systems. Together, these findings make a case for fMRS as an essential complement to fMRI for interpreting haemodynamic observations in their neurochemical context— with implications for how we design and interpret studies of both healthy brain function and psychotropic drug action.